Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

Next predicted deadline: Oct 11, 2023 (Full proposal)

Later predicted deadlines: Dec 11, 2023 (Letter of inquiry), Jan 11, 2024 (Full proposal), Jan 13, 2024 (Letter of inquiry), Feb 13, 2024 (Full proposal), May 11, 2024 (Letter of inquiry), Jun 11, 2024 (Full proposal), Aug 11, 2024 (Letter of inquiry), Sep 11, 2024 (Full proposal), Sep 11, 2024 (Letter of inquiry), Oct 11, 2024 (Full proposal), Dec 10, 2024 (Letter of inquiry), Jan 10, 2025 (Full proposal), Jan 11, 2025 (Letter of inquiry), Feb 11, 2025 (Full proposal), Apr 12, 2025 (Letter of inquiry), May 11, 2025 (Letter of inquiry), May 12, 2025 (Full proposal), Jun 11, 2025 (Full proposal), Aug 11, 2025 (Letter of inquiry), Sep 11, 2025 (Full proposal)

Grant amount: Unspecified amount

Funding uses: Training / Capacity Building, Research

Location of project: Anywhere in the world

Location of residency: Anywhere in the world

Overview:

NOTE: All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates: February 10, 2023, June 13, 2023, October 11, 2023, February 13, 2024, June 11, 2024 , October 11, 2024, February 11, 2025 and June 11, 2025 by 5:00 PM local time of applicant organization.

All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates: January 11, 2023, May 11, 2023, September 11, 2023,, January 11, 2024, May 11, 2024, September 11, 2024, January 10, 2025, May 12, 2025 and September 11, 2025 by 5:00 PM local time of applicant organization.

This Funding Opportunity Announcement (FOA) supports applications for a collaborating Data Coordinating Center (DCC) for investigator-initiated multi-site clinical trials including efficacy, comparative effectiveness, pragmatic and/or implementation research clinical trials. These trials may include ones that test different therapeutic, behavioral, and/or prevention strategies. Trials for which this FOA applies must be relevant to the research mission of the NHLBI and meet the NIH definition of a clinical trial (see NOT-OD-15-015). For additional information about the mission, strategic vision, and research priorities of the NHLBI, applicants are encouraged to consult the NHLBI website.This FOA will utilize a cooperative agreement mechanism of award and runs in parallel with a companion FOA (PAR-22-NNN) that encourages applications for a collaborating Clinical Coordinating Center (CCC). The objective of the DCC application is to present a comprehensive plan to provide overall project coordination, administration, data management, and biostatistical support for the clinical trial proposed in the collaborating CCC application.Both a DCC application and a collaborating CCC application must be submitted on the same application due date for consideration by NHLBI.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.